Ettore Luzi
Department of Surgery and Translational Medicine (DCMT)
University of Florence
Ettore Luzi has not added Biography.
If you are Ettore Luzi and would like to personalize this page please email our Author Liaison for assistance.
Phosphodiester oligonucleotides inhibit mitosis and trigger apoptosis by a non-antisense, p53-mediated mechanism.
Antisense & nucleic acid drug development Feb, 2002 | Pubmed ID: 12022687
Downregulation of bcl-2 expression in lymphoma cells by bcl-2 ARE-targeted modified, synthetic ribozyme.
Cancer gene therapy Mar, 2003 | Pubmed ID: 12637941
Multiple endocrine neoplasia type 1.
Orphanet journal of rare diseases , 2006 | Pubmed ID: 17014705
Multiple endocrine neoplasia type 2.
Orphanet journal of rare diseases , 2006 | Pubmed ID: 17105651
Osteogenic differentiation of human adipose tissue-derived stem cells is modulated by the miR-26a targeting of the SMAD1 transcription factor.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research Feb, 2008 | Pubmed ID: 18197755
Multiple endocrine neoplasms.
Best practice & research. Clinical rheumatology Mar, 2008 | Pubmed ID: 18328987
Modulatory effect of farnesyl pyrophosphate synthase (FDPS) rs2297480 polymorphism on the response to long-term amino-bisphosphonate treatment in postmenopausal osteoporosis.
Current medical research and opinion Sep, 2008 | Pubmed ID: 18687167
Germline mutations in MEN1 and BRCA1 genes in a woman with familial multiple endocrine neoplasia type 1 and inherited breast-ovarian cancer syndromes: a case report.
Cancer genetics and cytogenetics Nov, 2009 | Pubmed ID: 19837273
Multiple endocrine neoplasia type 1 (MEN1): not only inherited endocrine tumors.
Genetics in medicine : official journal of the American College of Medical Genetics Dec, 2009 | Pubmed ID: 19904212
Mammalian Pumilio 2 regulates dendrite morphogenesis and synaptic function.
Proceedings of the National Academy of Sciences of the United States of America Feb, 2010 | Pubmed ID: 20133610
Are microRNAs involved in the endocrine-specific pattern of tumorigenesis in multiple endocrine neoplasia type 1?
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists Jul-Aug, 2011 | Pubmed ID: 21613051
MicroRNA Role in Thyroid Cancer Development.
Journal of thyroid research , 2011 | Pubmed ID: 21687652
The regulatory network menin-microRNA 26a as a possible target for RNA-based therapy of bone diseases.
Nucleic acid therapeutics Apr, 2012 | Pubmed ID: 22409234
The negative feedback-loop between the oncomir Mir-24-1 and menin modulates the Men1 tumorigenesis by mimicking the "Knudson's second hit".
PloS one , 2012 | Pubmed ID: 22761894
COL1A1 Sp1 variation and bone phenotypes in an Italian population.
Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases May, 2013 | Pubmed ID: 24133532
PTH-C1: a rat continuous cell line expressing the parathyroid phenotype.
Endocrine Sep, 2014 | Pubmed ID: 24627164
Osteogenic differentiation of adipose tissue-derived mesenchymal stem cells on nanostructured Ti6Al4V and Ti13Nb13Zr.
Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases Sep-Dec, 2015 | Pubmed ID: 26811701
An autoregulatory network between menin and pri-miR-24-1 is required for the processing of its specific modulator miR-24-1 in BON1 cells.
Molecular bioSystems May, 2016 | Pubmed ID: 27098433
RISC-mediated control of selected chromatin regulators stabilizes ground state pluripotency of mouse embryonic stem cells.
Genome biology , 2016 | Pubmed ID: 27154007
JoVEについて
Copyright © 2023 MyJoVE Corporation. All rights reserved